Search results for the GEO ID: GSE44905
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM1093796
GPL570
LNCaP_vehicle_rep1 LNCaP_vehicle cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: vehicle (DMSO) for 16hrs A(H0046766.CEL)
GSM1093797
GPL570
LNCaP_vehicle_rep2 LNCaP_vehicle cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: vehicle (DMSO) for 16hrs A(H0046767.CEL)
GSM1093798
GPL570
LNCaP_vehicle_rep3 LNCaP_vehicle cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: vehicle (DMSO) for 16hrs A(H0046768.CEL)
GSM1093799
GPL570
LNCaP_DHT 100 nM_rep1 LNCaP_DHT 100 nM cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 100 nM DHT for 16hrs B(H0046769.CEL)
GSM1093800
GPL570
LNCaP_DHT 100 nM_rep2 LNCaP_DHT 100 nM cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 100 nM DHT for 16hrs B(H0046770.CEL)
GSM1093801
GPL570
LNCaP_DHT 100 nM_rep3 LNCaP_DHT 100 nM cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 100 nM DHT for 16hrs B(H0046771.CEL)
GSM1093802
GPL570
LNCaP_enzalutamide 1 x 10E-6 M plus vehicle_rep1 LNCaP_enzalutamide 1 x 10E-6 M plus vehicle cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 1 µM enzalutamide plus vehicle for 16hrs C(H0046772.CEL)
GSM1093803
GPL570
LNCaP_enzalutamide 1 x 10E-6 M plus vehicle_rep2 LNCaP_enzalutamide 1 x 10E-6 M plus vehicle cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 1 µM enzalutamide plus vehicle for 16hrs C(H0046773.CEL)
GSM1093804
GPL570
LNCaP_enzalutamide 1 x 10E-6 M plus vehicle_rep3 LNCaP_enzalutamide 1 x 10E-6 M plus vehicle cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 1 µM enzalutamide plus vehicle for 16hrs C(H0046774.CEL)
GSM1093805
GPL570
LNCaP_enzalutamide 1 x 10E-5 M plus vehicle_rep1 LNCaP_enzalutamide 1 x 10E-5 M plus vehicle cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 10 µM enzalutamide plus vehicle for 16hrs D(H0046775.CEL)
GSM1093806
GPL570
LNCaP_enzalutamide 1 x 10E-5 M plus vehicle_rep2 LNCaP_enzalutamide 1 x 10E-5 M plus vehicle cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 10 µM enzalutamide plus vehicle for 16hrs D(H0046776.CEL)
GSM1093807
GPL570
LNCaP_enzalutamide 1 x 10E-5 M plus vehicle_rep3 LNCaP_enzalutamide 1 x 10E-5 M plus vehicle cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 10 µM enzalutamide plus vehicle for 16hrs D(H0046777.CEL)
GSM1093808
GPL570
LNCaP_enzalutamide 1 x 10E-6 M plus DHT 100 nM_rep1 LNCaP_enzalutamide 1 x 10E-6 M plus DHT 100 nM cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 1 µM enzalutamide plus DHT 100 nM for 16hrs E(H0046778.CEL)
GSM1093809
GPL570
LNCaP_enzalutamide 1 x 10E-6 M plus DHT 100 nM_rep2 LNCaP_enzalutamide 1 x 10E-6 M plus DHT 100 nM cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 1 µM enzalutamide plus DHT 100 nM for 16hrs E(H0046779.CEL)
GSM1093810
GPL570
LNCaP_enzalutamide 1 x 10E-6 M plus DHT 100 nM_rep3 LNCaP_enzalutamide 1 x 10E-6 M plus DHT 100 nM cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 1 µM enzalutamide plus DHT 100 nM for 16hrs E(H0046780.CEL)
GSM1093811
GPL570
LNCaP_enzalutamide 1 x 10E-5 M plus DHT 100 nM_rep1 LNCaP_enzalutamide 1 x 10E-5 M plus DHT 100 nM cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 10 µM enzalutamide plus DHT 100 nM for 16hrs F(H0046781.CEL)
GSM1093812
GPL570
LNCaP_enzalutamide 1 x 10E-5 M plus DHT 100 nM_rep2 LNCaP_enzalutamide 1 x 10E-5 M plus DHT 100 nM cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 10 µM enzalutamide plus DHT 100 nM for 16hrs F(H0046782.CEL)
GSM1093813
GPL570
LNCaP_enzalutamide 1 x 10E-5 M plus DHT 100 nM_rep3 LNCaP_enzalutamide 1 x 10E-5 M plus DHT 100 nM cell line: LNCaP cell type: left supraclavicular lymph node metastatic prostate carcinoma cells treated with: 10 µM enzalutamide plus DHT 100 nM for 16hrs F(H0046783.CEL)
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes